Brensocatib, the first FDA-approved medication to treat non-cystic fibrosis bronchiectasis, can reduce symptoms of the chronic lung condition by targeting inflammation.

A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.

Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and ...

Italy: A new cross-sectional study published in Respiratory Research has highlighted a significant association between vertebral fractures and impaired lung function in patients with ...

Nutrition is more than just calories, carbohydrates and protein; it can be a powerful tool in managing lung disease and ...

Although e-cigarettes are often considered safer than conventional cigarettes, their vapor still poisons lung cells and ...

The lungs are rich in tiny blood vessels and delicate connective tissue. Just like high blood sugar can damage blood vessels ...

Cough sounds carry disease-specific acoustic signatures. By analysing these signatures using an AI-based algorithm, the software attempts to detect underlying respiratory abnormalities.

Travis Corbitt's struggles to breathe led to his retirement and reliance on an oxygen tank.

Dr. Joshua Sabari tells CURE that surgery, radiation and systemic therapy can affect the lungs, and he urges exercise and reporting new symptoms early. In an interview with CURE, Dr. Joshua Sabari, a ...

A novel test based on the levels and composition of certain proteins in mucus, called mucins, may help assess lung health in people with chronic obstructive pulmonary disease (COPD), according to a ...